5 min read
Zhong Shanshan's net worth stood at $68.1 billion as of Forbes' "10 Richest Chinese Billionaires 2026" list, published 10 March 2026 alongside Forbes' 40th annual World's Billionaires List, ranking the Nongfu Spring and Wantai Biological founder 2nd in China, just behind ByteDance's Zhang Yiming. Five months later, the Bloomberg Billionaires Index put him at $59.3 billion, 30th globally, as of August 2026. The gap, nearly $9 billion, comes two years after a nationalist boycott briefly hit his bottled-water empire, and it arrives in the same month both of his companies posted real news: a strong earnings report and a vaccine launch.
Forbes' "10 Richest Chinese Billionaires 2026" list, published 10 March 2026, placed Zhong Shanshan 2nd nationally at $68.1 billion, trailing only ByteDance founder Zhang Yiming's $69.3 billion. The Bloomberg Billionaires Index, as of August 2026, tracked him at $59.3 billion, 30th in its global ranking. Both trackers price the same two underlying stakes, so the roughly $8.8 billion gap between them is a genuine same-period disagreement, not a change over time.
| Date | Publisher | Figure | Rank |
|---|---|---|---|
| 10 March 2026 | Forbes, 10 Richest Chinese Billionaires 2026 | $68.1 billion | 2nd in China |
| August 2026 | Bloomberg Billionaires Index | $59.3 billion | 30th globally |
Zhong, born in 1954 in Hangzhou, dropped out of school during the Cultural Revolution, worked construction, and later became a newspaper reporter before starting his business career in Hainan in 1988. He founded health-supplement maker Yangshengtang in 1993, then Nongfu Spring in 1996, now China's largest bottled-water producer, which listed in Hong Kong in 2020 under ticker 9633.HK. Bloomberg credits him with an 84.5% stake in Nongfu Spring. Separately, he controls Beijing Wantai Biological Pharmacy Enterprise (603392.SH), a vaccine and diagnostic-kit maker, through a combined direct-plus-Yangshengtang stake of 70.92% as of 25 August 2026. Neither 9633.HK nor 603392.SH appears in NetWort's curated ticker universe, checked against frontend/scripts/curated-tickers.mjs and backend/app/services/asset_symbol_service.py, so both are named here by ticker only, with no internal asset link.
Nongfu Spring's own interim results, filed 25 August 2026 and reported the same day by Bamboo Works, showed revenue of CNY 29.7 billion (about $4.42 billion), up 16% year on year, and net profit of CNY 8.89 billion, up 16.6%. Tea beverages, not water, drove it: tea revenue jumped 30.1% to CNY 13.1 billion, 44.2% of total revenue, evidence the company has recovered from the 2024 boycott below. On the same day, per BigGo Finance and Futunn, Zhong donated 33 million Wantai shares, 2.61% of its total capital, worth about RMB 927 million ($138.2 million) at that day's close, to the Fujian Xiang'an Innovation Laboratory Science and Technology Development Foundation, cutting his direct stake from 17.71% to 15.10%. Two weeks later, on 9 September 2026, Wantai held the global first-inoculation event for Xinkening 9, its homegrown nine-valent HPV vaccine, in Xiamen, per Yicai Global and Futunn.
Unlike a fully private conglomerate such as Sukanto Tanoto's Royal Golden Eagle, Zhong's fortune sits in two separately listed, disclosed stakes, one on the Hong Kong exchange and one in Shanghai, both audited and priced daily. That should make it among the more knowable fortunes in this series. Yet Forbes and Bloomberg still land almost $9 billion apart across their two snapshots, a gap that most likely comes from differing valuation dates, currency conversion, and how each tracker weighs the Wantai stake against the larger Nongfu Spring one, the same kind of definitional gap this series found on Jensen Huang's Nvidia fortune, rather than any missing disclosure.
Two listed companies, both audited, both priced every trading day, and two major trackers still disagree by close to $9 billion. That is worth remembering before treating any single real-time "net worth" figure as exact rather than as one tracker's estimate on one day. For other fortunes in this series built on fully transparent, listed stakes, see: